Kai Eberhardt

Kai Eberhardt is the co-founder and CEO of Oviva, a digital health company that focuses on providing personalized diet and lifestyle therapy for people with conditions like diabetes, obesity, and heart disease. Here are some key details about Kai Eberhardt:

Background and Education

• Holds a PhD in Physical Chemistry from ETH Zürich2
• Completed an MS in Physics at ETH Zürich2
• Spent time at Harvard Medical School studying medical physics and magnetic resonance imaging2

Professional Experience

• Co-founded Oviva in August 2014 and has been serving as CEO since then2
• Previously worked as an Associate Principal at McKinsey & Company from 2012 to 20142
• Currently serves as an Advisor at Revent, an early-stage European tech fund2

Oviva and Its Mission

Kai Eberhardt co-founded Oviva with the goal of revolutionizing access to and outcomes for people with health conditions related to diet. The company aims to digitize medical nutritional therapy and improve value for the health system by lowering delivery costs.2 Under his leadership, Oviva has become a leading provider of digital diet and lifestyle therapy in Europe.3

Entrepreneurial Journey

Eberhardt's inspiration for Oviva came from his personal experience with cancer as a student, which motivated him to help people live healthier and happier lives.1 He and his co-founders identified a gap in the market where dieticians weren't meeting frequently enough with their patients. They hypothesized that reaching patients through their phones would be more effective.1

Business Model and Approach

Oviva's approach involves:

• Partnering with doctors for patient referrals3
• Working with health insurers to cover the costs of their care programs3
• Employing dedicated coaches and dietitians to work closely with patients3
• Utilizing a mobile app for patients to track progress, review information, and communicate with their care team3

Growth and Expansion

Under Eberhardt's leadership, Oviva has expanded across Switzerland, Germany, France, and the UK, backed by leading European venture capital firms.2 The company is focused on scaling within these large core markets rather than expanding into additional conditions.3

Kai Eberhardt's journey with Oviva demonstrates his commitment to improving healthcare through digital innovation, particularly in the realm of diet-related chronic diseases.